Zobrazeno 1 - 10
of 64
pro vyhledávání: '"drug receptor binding"'
Autor:
Dmitry S. Yakovlev, Pavel M. Vassiliev, Yana V. Agatsarskaya, Anastasia A. Brigadirova, Kira T. Sultanova, Maria O. Skripka, Alexander A. Spasov, Konstantin V. Savateev, Vladimir L. Rusinov, Dmitriy V. Maltsev
Publikováno v:
Research Results in Pharmacology
Research Results in Pharmacology 8(2): 69-75
Research Results in Pharmacology 8(2): 69-75
Introduction: Ligands of adenosine A1Rs are potential candidates for the development of drugs for the treatment of paroxysmal supraventricular tachycardia, angina pectoris, hypertriglyceridemia, type 2 diabetes mellitus, neuropathic pain, and heart f
Autor:
Laura Sánchez-García, Isolda Casanova, Gordon A. Morris, Ramon Mangues, Victor Pallarès, Eric Voltà-Durán, Ugutz Unzueta, Patricia Álamo, María Virtudes Céspedes, Alejandro Sánchez-Chardi, Naroa Serna, Julieta M. Sánchez, Aïda Falgàs, Antonio Villaverde, Esther Vázquez
Publikováno v:
Pharmaceutics
Volume 12
Issue 11
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Pharmaceutics, Vol 12, Iss 1004, p 1004 (2020)
Volume 12
Issue 11
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Pharmaceutics, Vol 12, Iss 1004, p 1004 (2020)
Fluorescent dye labeling is a common strategy to analyze the fate of administered nanoparticles in living organisms. However, to which extent the labeling processes can alter the original nanoparticle biodistribution has been so far neglected. In thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ab8ac211f8a7e66978465658e5493e1
https://www.mdpi.com/1999-4923/12/11/1004
https://www.mdpi.com/1999-4923/12/11/1004
Publikováno v:
Biosensors and Bioelectronics. 100:139-147
Schizophrenia treatment may see a paradigm shift due to development of new atypical antipsychotic drugs (APDs), with better tolerability due to more selective dopamine (DA) receptor blockade. Monitoring of these APD candidates in biological fluids is
Autor:
Gilli, Gastone, author, Gilli, Paola, author
Publikováno v:
The Nature of the Hydrogen Bond : Outline of a Comprehensive Hydrogen Bond Theory, 2009, ill.
Externí odkaz:
https://doi.org/10.1093/acprof:oso/9780199558964.003.0008
Publikováno v:
International Journal of Pharmacy and Pharmaceutical Sciences. 8(1):5-10
By integrating knowledge gained by pharmacogenetic, neuroanatomical and pharmacological studies, a model can be constructed how serotonin (5-HT) affects the vulnerability to induce tardive dyskinesia. From neuroanatomical studies, it can be concluded
Publikováno v:
International Journal of Pharmacy and Pharmaceutical Sciences, 8(1), 5-10. International Journal of Pharmacy and Pharmaceutical Science
University of Groningen
University of Groningen
By integrating knowledge gained by pharmacogenetic, neuroanatomical and pharmacological studies, a model can be constructed how serotonin (5-HT) affects the vulnerability to induce tardive dyskinesia. From neuroanatomical studies, it can be concluded
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7471da562e8880dcd5e6ed597719bb06
https://research.rug.nl/en/publications/2ac80d1e-aaad-4173-bc28-ab50a964ca33
https://research.rug.nl/en/publications/2ac80d1e-aaad-4173-bc28-ab50a964ca33
Autor:
Ednir de Oliveira Vizioli, Man Chin Chung, Jean Leandro dos Santos, Priscila Longhin Bosquesi, Paulo Renato Yamasaki, Pedro Malatesta
Publikováno v:
Pharmaceuticals, Vol 5, Iss 10, Pp 1128-1146 (2012)
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Pharmaceuticals
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Pharmaceuticals
Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-27T11:27:06Z No. of bitstreams: 0Bitstream added on 2014-05-27T14:42:27Z : No. of bitstreams: 1 2-s2.0-84869206693.pdf: 345052 bytes, checksum: af1f663f5bb60b9d0121f
Publikováno v:
Pharmaceutisch Weekblad. 145(20):79-85
Objective: To construct a model for classification of antidepressants on the basis of their binding properties to six common transporter and receptor sites. Design and methods: Receptor binding was quantified by calculating receptor/ transporter occu
Autor:
Mario Cazzola, Maria Gabriella Matera
Publikováno v:
Drugs. 67:503-515
There has been a real interest recently in developing once-daily beta(2)-adrenoceptor agonists (ultra-long-acting beta(2)-adrenoceptor agonists [ultra-LABAs]) for treating asthma and chronic obstructive pulmonary disease (COPD) in an attempt to simpl
Autor:
Ganesh A. Thakur, Shakir D. AlSharari, Roger L. Papke, M. Imad Damaj, Abhijit R. Kulkarni, Deniz Bagdas, Timothy Gould
The alpha 7 nicotinic acetylcholine receptor (nAChR) is a promising drug target for a number of neurological disorders including chronic pain and inflammatory diseases. Since alpha 7 can function as a ligand-gated ion channel, drug development initia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe121918cabb452b0566ca7cbb267bc6
https://aperta.ulakbim.gov.tr/record/82037
https://aperta.ulakbim.gov.tr/record/82037